Simple test could unlock better monitoring for rare metabolic disorders
NCT ID NCT05671666
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study is testing a new way to measure how well the urea cycle works in healthy people and in patients with urea cycle disorders (UCDs). Participants receive a safe, non-radioactive tracer, and blood samples are taken over a few hours. The goal is to develop a better tool for evaluating current and future treatments for UCDs.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- stable ammonium chloride isotope tracer
- What this could lead to
- If successful, this test could provide a better way to measure how well the urea cycle works, helping to evaluate new treatments for urea cycle disorders.
- What could go wrong
- This is an early diagnostic study, not a treatment trial. The test may not prove useful for all patients or may not be widely adopted.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for UREA CYCLE DISORDERS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
University Children's Hospital
RECRUITINGZurich, Canton of Zurich, 8008, Switzerland
More trials for these conditions
Other studies related to the condition(s) this trial covers.